Cancer Research

Dual-Drug Attack Overcomes Lung Cancer Resistance
Research & Development Dual-Drug Attack Overcomes Lung Cancer Resistance

A formidable new strategy has emerged in the fight against a particularly stubborn form of lung cancer, offering a beacon of hope for patients whose tumors have developed resistance to frontline treatments. Researchers from the Medical University of Vienna have pioneered a novel combination therapy

Why Are States Rewriting America's Health Rules?
Research & Development Why Are States Rewriting America's Health Rules?

A conservative West Virginia lawmaker and a progressive California governor rarely find common ground, yet they have become improbable allies in a sweeping national movement to fundamentally reshape what Americans eat and how public health is managed. This decentralized but powerful crusade,

Study Reveals a Weakness in Aggressive Breast Cancer
Research & Development Study Reveals a Weakness in Aggressive Breast Cancer

For one of the most aggressive forms of breast cancer, the very molecular machinery that fuels its relentless growth has now been identified as its most critical and exploitable vulnerability, opening a new front in the war against this disease. This groundbreaking discovery shifts the focus from

Cancer Digital Twin Technology – Review
Tech & Innovation Cancer Digital Twin Technology – Review

For decades, oncology has relied on a static snapshot of a tumor, a single frame from a complex biological film, to guide treatment decisions. The Cancer Digital Twin Technology represents a significant advancement in personalized medicine and oncology. This review will explore the evolution of the

Can a Polyp Test Reveal Hidden Cancer Risk?
Research & Development Can a Polyp Test Reveal Hidden Cancer Risk?

A recent international study is fundamentally changing the way clinicians understand and diagnose hereditary colorectal cancer, revealing that a direct analysis of colorectal polyp DNA can uncover critical information that standard blood tests frequently overlook. This groundbreaking research, a

Is WGS the Key to Unlocking PARP Inhibitor Therapy?
Research & Development Is WGS the Key to Unlocking PARP Inhibitor Therapy?

A comprehensive and detailed analysis from a recent study is reshaping the landscape of precision oncology, revealing the significant potential of whole-genome sequencing (WGS) to revolutionize how patient responses to PARP inhibitor cancer treatments are predicted. The findings, published in the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later